Mosaic ImmunoEngineering Inc. SEC filings CPMV
Mosaic ImmunoEngineering Inc. has 553 filings in SEC EDGAR's recent list, going back to Dec 11, 1995. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 2, 2025 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 2, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 3, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 5, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Dec 29, 2020 | Nov 30, 2020 |
| 10-Q | Quarterly report | Oct 15, 2020 | Aug 31, 2020 |
| 10-Q | Quarterly report | Apr 8, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 14, 2020 | Nov 30, 2019 |
| 10-Q | Quarterly report | Oct 11, 2019 | Aug 31, 2019 |
| 10-Q | Quarterly report | Apr 15, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 14, 2019 | Nov 30, 2018 |
| 10-Q | Quarterly report | Oct 15, 2018 | Aug 31, 2018 |
| 10-Q | Quarterly report | Apr 16, 2018 | Feb 28, 2018 |
| 10-Q | Quarterly report | Jan 16, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Oct 16, 2017 | Aug 31, 2017 |
| 10-Q | Quarterly report | Apr 13, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 17, 2017 | Nov 30, 2016 |
| 10-Q | Quarterly report | Oct 17, 2016 | Aug 31, 2016 |
| 10-Q | Quarterly report | Apr 14, 2016 | Feb 29, 2016 |
| 10-Q | Quarterly report | Jan 14, 2016 | Nov 30, 2015 |
| 10-Q | Quarterly report | Oct 15, 2015 | Aug 31, 2015 |
| 10-Q | Quarterly report | Apr 14, 2015 | Feb 28, 2015 |
| 10-Q | Quarterly report | Jan 14, 2015 | Nov 30, 2014 |
| 10-Q | Quarterly report | Oct 15, 2014 | Aug 31, 2014 |
| 10-Q | Quarterly report | Apr 14, 2014 | Feb 28, 2014 |
| 10-Q | Quarterly report | Jan 14, 2014 | Nov 30, 2013 |
| 10-Q | Quarterly report | Oct 15, 2013 | Aug 31, 2013 |
| 10-Q | Quarterly report | Apr 15, 2013 | Feb 28, 2013 |
| 10-Q | Quarterly report | Jan 14, 2013 | Nov 30, 2012 |
| 10-Q | Quarterly report | Oct 15, 2012 | Aug 31, 2012 |
| 10-Q | Quarterly report | Apr 16, 2012 | Feb 29, 2012 |
| 10-Q | Quarterly report | Jan 17, 2012 | Nov 30, 2011 |
| 10-Q | Quarterly report | Oct 17, 2011 | Aug 31, 2011 |
| 10-Q | Quarterly report | Apr 11, 2011 | Feb 28, 2011 |
| 10-Q | Quarterly report | Jan 14, 2011 | Nov 30, 2010 |
| 10-Q | Quarterly report | Oct 12, 2010 | Aug 31, 2010 |
| 10-Q | Quarterly report | Apr 9, 2010 | Feb 28, 2010 |
| 10-Q | Quarterly report | Jan 11, 2010 | Nov 30, 2009 |
| 10-Q | Quarterly report | Oct 9, 2009 | Aug 31, 2009 |
| 10-Q | Quarterly report | Apr 9, 2009 | Feb 28, 2009 |
| 10-Q | Quarterly report | Jan 9, 2009 | Nov 30, 2008 |
| 10-Q | Quarterly report | Oct 10, 2008 | Aug 31, 2008 |
| 10-Q | Quarterly report | Apr 9, 2008 | Feb 29, 2008 |
| 10-Q | Quarterly report | Jan 9, 2008 | Nov 30, 2007 |
| 10-Q | Quarterly report | Oct 10, 2007 | Aug 31, 2007 |
| 10-Q | Quarterly report | Apr 20, 2007 | Feb 28, 2007 |
| 10-Q | Quarterly report | Jan 16, 2007 | Nov 30, 2006 |
| 10-Q | Quarterly report | Oct 23, 2006 | Aug 31, 2006 |
| 10-Q | Quarterly report | Apr 21, 2003 | Feb 28, 2003 |
| 10-Q | Quarterly report | Jan 22, 2003 | Nov 30, 2002 |
| 10-Q | Quarterly report | Oct 18, 2002 | Aug 31, 2002 |
| 10-Q | Quarterly report | Apr 22, 2002 | Feb 28, 2002 |
| 10-Q | Quarterly report | Jan 22, 2002 | Nov 30, 2001 |
| 10-Q | Quarterly report | Oct 22, 2001 | Aug 31, 2001 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CPMV (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Huntington Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 836564
- Former names
- PATRIOT SCIENTIFIC CORP (until Nov 19, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.